Ajanta Pharma launches Memantine Hydrochloride Tablets

In US market

Ajanta Pharma announced the launch of Memantine Hydrochloride Tablets in the US market through its wholly owned subsidiary - Ajanta Pharma USA Inc. Memantine Hydrochloride is an anti-dementia drug and is a bio-equivalent generic version of Namenda. The Company has launched it in 2 strengths 5 mg and 10 mg tablets to address different levels of treatment.

Powered by Capital Market - Live News